Cellebrite DI (CLBT) Share-based Compensation (2021 - 2025)

Cellebrite DI's Share-based Compensation history runs 5 years deep, the most recent figure standing at -$2.0 million for Q4 2025.

• On a quarterly basis, Share-based Compensation fell 3849.06% year-over-year to -$2.0 million in Q4 2025; TTM through Dec 2025 was $30.9 million, a 122.04% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, up 492.04% from the prior year.
• Share-based Compensation declined to -$2.0 million in Q4 2025 per CLBT's latest filing, from $15.3 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $16.8 million in Q2 2025 and bottomed at -$2.0 million in Q4 2025.
• The 5-year median for Share-based Compensation is $2.9 million (2022), against an average of $4.0 million.
• Biggest YoY gain for Share-based Compensation was 847.28% in 2025; the steepest drop was 3849.06% in 2025.
• Year by year, Share-based Compensation stood at $1.7 million in 2021, then jumped by 128.0% to $3.8 million in 2022, then retreated by 18.01% to $3.1 million in 2023, then tumbled by 98.29% to $53000.0 in 2024, then sank by 3849.06% to -$2.0 million in 2025.
• Per Business Quant, the three latest CLBT Share-based Compensation figures stand at -$2.0 million (Q4 2025), $15.3 million (Q3 2025), and $16.8 million (Q2 2025).